Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

65.04
Delayed Data
As of 4:00pm ET
 +0.11 / +0.17%
Today’s Change
55.10
Today|||52-Week Range
66.80
+10.48%
Year-to-Date
Hendley & Co Inc Buys Texas Instruments Inc, T. ...
3:38pm / GuruFocus News - Paid Partner Content
AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk
May 24 / Zacks.com - Paid Partner Content
New Stock Research Reports for Merck, 3M and United Technologies
2:29pm / Zacks.com - Paid Partner Content
Merck Presents Phase II Data on Chronic Cough Candidate
May 23 / Zacks.com - Paid Partner Content
Radius Health Osteoporosis Drug Positive in Phase III Study
10:01am / Zacks.com - Paid Partner Content
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna
May 23 / GuruFocus News - Paid Partner Content
Ibex Wealth Advisors Buys Raymond James Financial Inc, Valero Energy Corp, Cisco Syst...
7:38am / GuruFocus News - Paid Partner Content
Merck Declares 47 Cent Quarterly Dividend
May 23 / TheStreet.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers
May 24 / Zacks.com - Paid Partner Content
Merck & Co Faces Financial Hit From U.K. Regulator Over Drug Pricing
May 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close64.93
Today’s open64.97
Day’s range64.66 - 65.12
Volume7,095,873
Average volume (3 months)9,510,778
Market cap$175.2B
Dividend yield2.89%
Data as of 4:00pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+1.37%
Earnings growth (next 5 years)+4.70%
Revenue growth (last year)+1.86%
P/E ratio41.4
Price/Sales4.15
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.05-0.06%
PFEPfizer+0.11+0.34%
SNYSanofi-0.12-0.24%
GSKGlaxoSmithKline-0.38-0.88%
Data as of 4:02pm ET, 05/25/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts